Temporal association between the age-specific incidence of Guillain-Barré syndrome and SARS-CoV-2 vaccination in Republic of Korea: a nationwide time-series correlation studyopen access
- Authors
- Lee, Hyunju; Kwon, Donghyok; Park, Seoncheol; Park, Seung Ri; Chung, Darda; Ha, Jongmok
- Issue Date
- Jun-2023
- Publisher
- KOREA DISEASE CONTROL & PREVENTION AGENCY
- Keywords
- COVID-19; COVID-19 vaccines; Guillain-Barre syndrome; SARS-CoV-2
- Citation
- OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, v.14, no.3, pp.224 - 231
- Indexed
- SCOPUS
KCI
- Journal Title
- OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES
- Volume
- 14
- Number
- 3
- Start Page
- 224
- End Page
- 231
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189654
- DOI
- 10.24171/j.phrp.2023.0050
- ISSN
- 2210-9099
- Abstract
- Objectives: The incidence of Guillain-Barré syndrome (GBS) changed significantly during the coronavirus disease 2019 (COVID-19) pandemic. Emerging reports suggest that viral vector-based vaccines may be associated with an elevated risk of GBS.
Methods: In this nationwide time-series correlation study, we examined the age-specific incidence of GBS from January 2011 to August 2022, as well as data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations and infections from February 2021 to August 2022. We compared the forecasted estimates of age-specific GBS incidence, using the pre-SARS-CoV-2 period as a benchmark, with the actual incidence observed during the post-vaccination period of the pandemic. Furthermore, we assessed the temporal association between GBS, SARS-CoV-2 vaccinations, and COVID-19 for different age groups.
Results: In the age group of 60 and older, the rate ratio was significantly elevated during June-August and November 2021. A significant, strong positive association was observed between viral vector-based vaccines and GBS incidence trends in this age group (r=0.52, p=0.022). For the 30 to 59 years age group, the rate ratio was notably high in September 2021. A statistically significant, strong positive association was found between mRNA-based vaccines and GBS incidence in this age group (r=0.61, p=0.006).
Conclusion: Viral vector-based SARS-CoV-2 vaccines were found to be temporally associated with an increased risk of GBS, particularly in older adults. To minimize age-specific and biological mechanism-specific adverse events, future vaccination campaigns should adopt a more personalized approach, such as recommending homologous mRNA-based SARS-CoV-2 vaccines for older adults to reduce the heightened risk of GBS.
- Files in This Item
-
- Appears in
Collections - 서울 자연과학대학 > 서울 수학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189654)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.